Screener
Amneal Pharmaceuticals, Inc. AMRX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s free cash flow?
- Amneal Pharmaceuticals, Inc. (AMRX) reported free cash flow of -$51.94M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s free cash flow decreased by 185.2% year-over-year, from $60.99M to -$51.94M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s free cash flow?
- Over 2 years (2023 to 2025), Amneal Pharmaceuticals, Inc.'s free cash flow has grown at a -9.0% compound annual growth rate (CAGR), from $325.71M to $269.93M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Amneal Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude